Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

Published Works

These Are The Top Priorities & Challenges For New CDER Director Patrizia Cavazzoni, M.D. Life Sciences Connect

Partner Lynn Mehler and Counsel Lowell Zeta pen a guest column for Life Sciences Connect where they discuss the recent appointment of a new Center for Drug Evaluation and Research director...

Published Works

2021 Chambers Global Practice Guide in Life Sciences Chambers Global Practice Guide

A team of lawyers from Hogan Lovells contributed to the 2021 Chambers Global Practice Guide in Life Sciences. They provided legal commentary and insights on Life Sciences industry trends...

Hogan Lovells Publications

Life sciences and health care horizons 2021

Companies in the life sciences and health care industry navigated unparalleled challenges in 2020. The pandemic forced the development and adoption of new technologies and innovations...

Hogan Lovells Publications

Proposed measures in Germany for safeguarding supply of critical goods in the combat against COVID-19

In the wake of combating the COVID-19 pandemic, the German federal government is proposing to enable further measures on a federal level. The proposal includes important measures concerning ...

Hogan Lovells Publications

Life sciences and health care horizons 2020

We are pleased to provide you with the third annual installment of our Life Sciences and Health Care Horizons guide. For each of these guides, we have asked our industry thought leaders...

Hogan Lovells Publications

Online sale of pharmaceuticals in Russia remains prohibited and lawmakers are yet to pass the bill allowing online sales

Russian law currently prohibits the online sale of pharmaceuticals and requires that pharmaceuticals must be sold only in stationary pharmacies operated by a person holding a pharmaceutical ...

News

FDA’s ‘Project Facilitate’ Pilot to Collect Metrics on Sponsor Expanded Access Denials Focus On Regulation

This morning, the U.S. Food and Drug Administration (FDA) announced it launched its new expanded access pilot called "Project Facilitate," a concierge call center under the Oncology Center...

Loading data